Pages that link to "Q34371320"

The following pages link to Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains (Q34371320):

Displaying 24 items.

• RNA interference: from gene silencing to gene-specific therapeutics (Q33215530) (← links)
• Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system (Q33610280) (← links)
• Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells (Q35241638) (← links)
• Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection (Q35852460) (← links)
• Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophages (Q35911433) (← links)
• Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. (Q35942658) (← links)
• Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. (Q36055034) (← links)
• New therapeutics targets in chronic viral cardiomyopathy. (Q36331845) (← links)
• RNA interference: its use as antiviral therapy. (Q36440302) (← links)
• Interfering antiviral immunity: application, subversion, hope? (Q36497229) (← links)
• A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs (Q37331638) (← links)
• Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction (Q37354387) (← links)
• Lentiviral delivery of short hairpin RNAs (Q37430557) (← links)
• RNA interference technologies and therapeutics: from basic research to products (Q37597161) (← links)
• RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA? (Q37678411) (← links)
• Interaction of cationic carbosilane dendrimers and their complexes with siRNA with erythrocytes and red blood cell ghosts. (Q38169458) (← links)
• Construction of a multiple targeting RNAi plasmid that inhibits target gene expression and FMDV replication in BHK-21 cells and suckling mice (Q39707130) (← links)
• HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region (Q40037564) (← links)
• Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs (Q40198668) (← links)
• Silencing of HIV-1 with RNA interference: a multiple shRNA approach (Q40234514) (← links)
• The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference (Q40237024) (← links)
• siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects (Q40316045) (← links)
• Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells. (Q41159088) (← links)
• Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses (Q91908886) (← links)